Jayakumar Saikarthik, Ilango Saraswathi, Kumar K Senthil, Alassaf Abdullah, Aljabr Abdullah, Paramasivam Anand, Mickeymaray Suresh, Hawsah Yazeed Mohammed, Aldawish Ahmed Saad
Department of Basic Medical Sciences, College of Dentistry, Majmaah University, Al Majma'ah, Saudi Arabia.
Department of Medical Education, College of Dentistry, Majmaah University, Al Majma'ah, Saudi Arabia.
Front Med (Lausanne). 2022 May 4;9:900026. doi: 10.3389/fmed.2022.900026. eCollection 2022.
Vaccine hesitancy is a global public health threat. Understanding the role of psychological factors in vaccine hesitancy is often neglected and relatively less explored.
To analyze the relationship between mental health and COVID-19 vaccine hesitancy before and after the advent of COVID-19 vaccines (AC19V) in the general population of India and Saudi Arabia (KSA) which vary in severity of the pandemic and vaccine mandates.
A total of 677 adult participants from India and KSA participated in this cross-sectional online web-based survey. Sociodemographic details and current COVID-19 status pertaining to infection and vaccination were collected. Depression, anxiety, post-traumatic stress disorder (PTSD) symptoms, and perceptive need for mental health support (MHS) were assessed before and after AC19V. A newly constructed and validated COVID19 vaccine hesitancy scale-12 (COVID19-VHS12) scale was used to evaluate the COVID-19 vaccine hesitancy.
Prevalence and levels of depression and anxiety symptoms decreased significantly in Saudis but not in Indians after AC19V. PTSD symptoms showed a significant reduction in both India and KSA. Anxiety symptoms were higher in KSA than India before AC19V while PTSD was higher in India before and after AC19V. Except for the place of residence and employment status, the subgroups of sociodemographic variables which were at higher risk of negative mental health before AC19V showed improvement in their mental health after AC19V. The prevalence of COVID-19 vaccine hesitancy in India and KSA was 50.8% (95% CI 45.73-55.89%) and 55.7% (95% CI 50.16-61.31%), respectively. A bidirectional association between vaccine hesitancy and mental health was observed in KSA but not in India. Higher vaccine hesitancy favored higher levels of depression, anxiety, and perceptive need for MHS and vice versa in KSA. None of the mental health parameters predicted vaccine hesitancy in India, while higher vaccine hesitancy increased the risk of anxiety.
Vaccine hesitancy has a negative impact on mental health and vice versa over and above the impact of sociodemographic factors and COVID-19 vaccination and infection status which shows variations between India and KSA.
疫苗犹豫是一种全球公共卫生威胁。了解心理因素在疫苗犹豫中的作用常常被忽视,且相关探索相对较少。
分析在印度和沙特阿拉伯(KSA)的普通人群中,新冠疫苗(AC19V)出现前后心理健康与新冠疫苗犹豫之间的关系,这两个地区的疫情严重程度和疫苗强制要求有所不同。
共有来自印度和KSA的677名成年参与者参与了这项基于网络的横断面在线调查。收集了社会人口学详细信息以及与感染和疫苗接种相关的当前新冠疫情状况。在AC19V前后评估了抑郁、焦虑、创伤后应激障碍(PTSD)症状以及对心理健康支持(MHS)的感知需求。使用新构建并验证的新冠疫苗犹豫量表-12(COVID19-VHS12)来评估新冠疫苗犹豫情况。
AC19V后,沙特人的抑郁和焦虑症状患病率及水平显著下降,但印度人没有。印度和KSA的PTSD症状均显著减少。AC19V前,KSA的焦虑症状高于印度,而AC19V前后印度的PTSD症状均更高。除居住地点和就业状况外,AC19V前心理健康状况较差风险较高的社会人口学变量亚组在AC19V后心理健康状况有所改善。印度和KSA的新冠疫苗犹豫患病率分别为50.8%(95%CI 45.73 - 55.89%)和55.7%(95%CI 50.16 - 61.31%)。在KSA观察到疫苗犹豫与心理健康之间存在双向关联,但在印度没有。在KSA,较高的疫苗犹豫倾向于导致更高水平的抑郁、焦虑以及对MHS的感知需求,反之亦然。在印度,没有任何心理健康参数能够预测疫苗犹豫,而较高的疫苗犹豫会增加焦虑风险。
疫苗犹豫对心理健康有负面影响,反之亦然,这种影响超出了社会人口学因素以及新冠疫苗接种和感染状况的影响,且印度和KSA之间存在差异。